Bridgeway Capital Management’s HOOKIPA Pharma HOOK Stock Holding History

Bridgeway Capital Management’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,750	Closed	-$62.3K	–	1302
2024 Q1	$62.3K	Hold	8,750	–	–	﹤0.01%	1254
2023 Q4	$70.9K	Hold	8,750	–	–	﹤0.01%	1289
2023 Q3	$53.9K	Hold	8,750	–	–	﹤0.01%	1295
2023 Q2	$77K	Sell	8,750 -9,010	-51%	-$100K	﹤0.01%	1292
2023 Q1	$131K	Sell	17,760 -2,320	-12%	-$20.8K	﹤0.01%	1184
2022 Q4	$163K	Hold	20,080	–	–	﹤0.01%	1137
2022 Q3	$269K	Buy	20,080 +12,350	+160%	+$190K	0.01%	1074
2022 Q2	$126K	Sell	7,730 -4,150	-35%	-$68.7K	﹤0.01%	1185
2022 Q1	$271K	Buy	11,880 +2,000	+20%	+$35.8K	0.01%	1108
2021 Q4	$230K	Sell	9,880 -2,940	-23%	-$118K	﹤0.01%	1140
2021 Q3	$755K	Buy	+12,820	New	+$930K	0.01%	913

Other funds holding HOOK

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bridgeway Capital Management's HOOK Position: Q2 2024 in Review

Bridgeway Capital Management sold out of HOOKIPA Pharma (HOOK) in Q2 2024, closing a stake of 8,750 shares — an estimated $62.3K sold.

Bridgeway Capital Management first reported a position in HOOK in Q3 2021 and held it in 11 quarters. The position peaked at $755K in Q3 2021. 40 funds tracked by Wall St. Rank hold HOOK as of Q2 2024.

Bridgeway Capital Management reported no remaining HOOKIPA Pharma position as of Q2 2024 after selling out during the quarter.
Bridgeway Capital Management sold 8,750 HOOKIPA Pharma shares in Q2 2024, an estimated $62.3K.
Bridgeway Capital Management first reported a position in HOOKIPA Pharma in Q3 2021 and held it in 11 quarters.
Bridgeway Capital Management's HOOKIPA Pharma position peaked at $755K in Q3 2021.
40 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2024.

Based on Bridgeway Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.